BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12215101)

  • 1. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion.
    Ip MS; Kumar KS
    Arch Ophthalmol; 2002 Sep; 120(9):1217-9. PubMed ID: 12215101
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
    Soto-Pedre E; Hernaez-Ortega MC
    Am J Ophthalmol; 2004 Mar; 137(3):596; author reply 596-7. PubMed ID: 15013911
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion.
    Jonas JB; Kreissig I; Degenring RF
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):782-3. PubMed ID: 12271378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
    Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
    Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
    Hayashi K; Hayashi H
    Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
    Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
    Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
    Williamson TH; O'Donnell A
    Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
    Kwong YY; Lai WW; Lam DS
    Am J Ophthalmol; 2004 Mar; 137(3):593-4; author reply 594. PubMed ID: 15013906
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
    Er H
    Am J Ophthalmol; 2006 Oct; 142(4):710; author reply 710. PubMed ID: 17011888
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion.
    Bashshur ZF; Ma'luf RN; Allam S; Jurdi FA; Haddad RS; Noureddin BN
    Arch Ophthalmol; 2004 Aug; 122(8):1137-40. PubMed ID: 15302653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.
    Cekiç O; Cakır M; Yazıcı AT; Alagöz N; Bozkurt E; Faruk Yılmaz O
    Curr Eye Res; 2010 Oct; 35(10):925-9. PubMed ID: 20858114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
    Patel PJ; Zaheer I; Karia N
    Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
    Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
    Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study.
    Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
    Acta Ophthalmol Scand; 2005 Oct; 83(5):600-4. PubMed ID: 16188000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.
    Gregori NZ; Rosenfeld PJ; Puliafito CA; Flynn HW; Lee JE; Mavrofrides EC; Smiddy WE; Murray TG; Berrocal AM; Scott IU; Gregori G
    Retina; 2006 Oct; 26(8):889-95. PubMed ID: 17031288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
    Hirano Y; Sakurai E; Yoshida M; Ogura Y
    Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion.
    Ozkiris A; Evereklioglu C; Erkiliç K; Ilhan O
    Eur J Ophthalmol; 2005; 15(1):96-101. PubMed ID: 15751246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal triamcinolone acetonide for patients with macular oedema due to central retinal vein occlusion in Taiwan.
    Cheng KC; Wu WC; Lin CJ
    Eye (Lond); 2009 Apr; 23(4):849-57. PubMed ID: 18535613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion.
    Senturk F; Ozdemir H; Karacorlu M; Karacorlu SA; Uysal O
    Retina; 2010 Sep; 30(8):1254-61. PubMed ID: 20827142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.